logo
Select company
Select metric
-1248.97%EBITDA Margin
VS
Market
5
Sector
18
Industry
33
History
-
$ 8.17Close
$ 6.38 - $ 27.03 52-Week Range
Ticker Information

Ticker

BCYC

Company Name

BICYCLE THERAPEUTICS PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BICYCLE THERAPEUTICS PLC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BCYC - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -240.81M-1248.97%$ 19.28M
3/31/2025$ -200.61M-779.93%$ 25.72M
12/31/2024$ -164.89M-467.45%$ 35.27M
9/30/2024$ -160.02M-433.67%$ 36.9M
6/30/2024$ -153.09M-386.86%$ 39.57M
3/31/2024$ -156.51M-376.15%$ 41.61M
12/31/2023$ -169.4M-627.96%$ 26.98M
9/30/2023$ -151.28M-609.26%$ 24.83M
6/30/2023$ -132.66M-589.13%$ 22.52M
3/31/2023$ -117.78M-759.93%$ 15.5M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BICYCLE THERAPEUTICS PLC's latest trailing twelve months (TTM) EBITDA % stands at -317.79%.
  • Over the past 5 years, BICYCLE THERAPEUTICS PLC's average EBITDA % has been -581.39%.
  • The median EBITDA % for BICYCLE THERAPEUTICS PLC during this period was -541.8%
  • BICYCLE THERAPEUTICS PLC reached its highest EBITDA % over the past 5 years at -317.79%.
  • The lowest EBITDA % recorded by BICYCLE THERAPEUTICS PLC in the same timeframe -1248.97%

BICYCLE THERAPEUTICS PLC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
ALMS : ALUMIS INC -1157.12%VIR : VIR BIOTECHNOLOGY INC -2808.94%ABUS : ARBUTUS BIOPHARMA CORP -344.62%ZBIO : ZENAS BIOPHARMA INC -1172.19%CAPR : CAPRICOR THERAPEUTICS INC -510.35%AUTL : AUTOLUS THERAPEUTICS PLC -759.93%QURE : UNIQURE NV -833.95%RLAY : RELAY THERAPEUTICS INC -3669.67%TNGX : TANGO THERAPEUTICS INC -572%FHTX : FOGHORN THERAPEUTICS INC -274.86%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for BICYCLE THERAPEUTICS PLC is calculated as follows: EBITDA [ $ -37.57M ] / Revenues [ $ 11.82M ]
(=) EBITDA % [ -317.79% ]

BCYC - EBITDA Margin, Last 5 years

-1248.97%

Minimum

Jun 30, 2025

-317.79%

Maximum

Sep 30, 2020

-581.39%

Average

-541.8%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%